The fair value adjustments are non-cash charges and are primarily a result of …
The stock increased 1.56% or $0.03 on August 16, reaching $1.95. About shares traded. Rexahn Pharmaceuticals, Inc. …
A year ago, they were trading at $2.75. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RNN at https://www.zacks.com/ap/RNN
CNBC11d
The stock’s market capitalization is 51.51M, it has a 52-week low of 0.13 and a 52-week high of 4.74. The share price of the company (RNN) was down -0.55%, with a high of 1.84 during the day and the volume of Rexahn Pharmaceuticals, …
Aug. 07, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company ... “We also effected a one-for-ten reverse stock split that we believe should enhance the …
Rexahn Pharmaceuticals, Inc. (NYSEMKT: RNN) is having an overwhelmingly rough day in the market today, and for good reason. The company announced that it would be moving forward with a reverse stock split, leading to fear among …
Rexahn Pharmaceuticals, Inc. (RNN - Free Report) was a big mover last session, as its shares rose above 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the …
ZACKS5mon
Artificial Neural Networks (ANN), Convolutional Neural Networks (CNN) and Recurrent Neural Networks (RNN) are some of the modern implementations ...
(See also: 8 Stages Of New Drug Development.) It has been a difficult year for shareholders of RNN stock, which has declined by 40.83% since January 1. The stock is off sharply from its 52-week high of $0.52 per share. Over the last 52 …